Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Industry continues dabbling with open innovation models

A Corrigendum to this article was published on 08 February 2012

This article has been updated

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 08 February 2012

    In the version of this article initially published, Richard Anderson is named incorrectly and so is his affiliation as director of the Initiative for Open Innovation at Queensland University of Technology, in Brisbane, Australia. The source’s correct name is Richard Jefferson and he is founder and CEO of Cambia, a not-for-profit biotech research institute based at the Queensland University of Technology, in Brisbane, Australia. The error has been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheridan, C. Industry continues dabbling with open innovation models. Nat Biotechnol 29, 1063–1065 (2011). https://doi.org/10.1038/nbt1211-1063a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1211-1063a

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research